OncXerna Therapeutics Announces New Biomarker Data from
62% vs. 25% overall response rates with navicixizumab plus paclitaxel in biomarker positive vs. biomarker negative patients using the Xerna™ TME Panel ...
Source: globenewswire.com
Xerna Panel News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Xerna Panel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.